Viracta Therapeutics, Inc. - Common Stock (NQ:VIRX)

0.0778 UNCHANGED

Last Price Updated: 4:00 PM EST, Feb 3, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viracta Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

What's going on in today's after hours session ↗

February 04, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Get insights into the top gainers and losers of Monday's after-hours session. ↗

February 03, 2025

The US market regular session of Monday is over, let's have a look at the top gainers and losers in the after hours session today.

Via Chartmill

Top movers in Monday's session ↗

February 03, 2025

Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.

Via Chartmill

Keep an eye on the top gainers and losers in Monday's session. ↗

February 03, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

Traders are paying attention to the gapping stocks in Monday's session. ↗

February 03, 2025

The market is filled with gapping stocks in Monday's session. Let's discover which stocks are showing gap-ups and gap-downs.

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

February 03, 2025

As the US market prepares to open on Monday, let's get an early glimpse into the pre-market session and identify the stocks leading the pack in terms of gains and losses.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 03, 2025

Via Benzinga

Why Triumph Group Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket ↗

February 03, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 27, 2024

Via Benzinga

Deal Dispatch: Party City Wraps Up, Big Lots Goes Bust, The Container Store Continues ↗

December 27, 2024

Via Benzinga

Masimo To Rally More Than 13%? Here Are 5 Top Analyst Forecasts For Friday ↗

December 27, 2024

Via Benzinga

US Stocks To Open Lower As Index Future Decline: Analysts Remain Upbeat About Santa Rally ↗

December 27, 2024

U.S. stock futures tumbled on Friday in premarket hours after a mixed Thursday. All four index futures slipped in trade.

Via Benzinga

Why Evaxion Biotech Shares Are Trading Higher By Around 62%; Here Are 20 Stocks Moving Premarket ↗

December 27, 2024

Via Benzinga

Constellium, Viracta Therapeutics And 3 Stocks To Watch Heading Into Friday ↗

December 27, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 04, 2024

Via Benzinga

Why Marvell Technology Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

December 04, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 27, 2024

Via Benzinga

VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q2 2024 ↗

August 14, 2024

VIRX stock results show that Viracta Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Why Is Cancer-Focused Penny Stock Viracta Therapeutics Trading Higher On Wednesday? ↗

August 14, 2024

Viracta Therapeutics stock gains after Phase 2 NAVAL-1 trial results for relapsed or refractory EBV+ PTCL cohort. The company plans pipeline reprioritization and a reduction in force.

Via Benzinga

Why Is Viracta Therapeutics (VIRX) Stock Up 42% Today? ↗

August 14, 2024

Viracta Therapeutics stock is up on Wednesday alongside as VIRX investors react to its most recent earnings report and business updates.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

August 14, 2024

Pre-market stock movers are a hot topic on Wednesday and we have all of the biggest stories traders need to know about this morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 08, 2024

It's time to dive into the biggest pre-market stock movers on Thursday morning with all of the latest news this morning!

Via InvestorPlace

Why Digital Turbine Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket ↗

August 08, 2024

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 11, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

June 11, 2024

It's time to start the day with a breakdown of the biggest pre-market stock movers worth checking out on Tuesday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 07, 2024

Pre-market stock movers are worth checking out on Friday as we dig into all of the biggest news affecting shares this morning!

Via InvestorPlace

VIRX Stock Earnings: Viracta Therapeutics Beats EPS for Q1 2024 ↗

May 09, 2024

VIRX stock results show that Viracta Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

3 Speculative Penny Stocks Offering High-Upside Potential for Under a Buck ↗

May 08, 2024

Although the concept of penny stocks under $1 is wildly speculative, these ideas could fly higher under the right circumstances.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

April 24, 2024

Via Benzinga

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 17, 2024

Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.